SPF
AZN icon

South Plains Financial’s AstraZeneca AZN Stock Holding History

South Plains Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.1K Buy
188
+44
+31% +$8.48K 0.02% 175
2025
Q4 		$26.4K Buy
+144
New +$25.3K 0.02% 200

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

South Plains Financial's AZN Position: Q1 2026 in Review

South Plains Financial increased its AstraZeneca (AZN) stake by 31% in Q1 2026, buying an estimated $8.48K and bringing the position to 188 shares worth $37.1K. The position accounts for 0.02% of the portfolio, ranked #175.

South Plains Financial first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • South Plains Financial held 188 shares of AstraZeneca worth $37.1K as of Q1 2026.
  • South Plains Financial bought 44 AstraZeneca shares in Q1 2026, an estimated $8.48K.
  • AstraZeneca made up 0.02% of South Plains Financial's portfolio in Q1 2026, its #175 holding.
  • South Plains Financial first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.